According to GuruFocus Insider Data, the recent CFO buys were: SunEdison Inc. (SUNE, Financial), Genpact Ltd. (G, Financial) and GenMark Diagnostics Inc. (GNMK, Financial).
SunEdison Inc.: EVP, CAO and CFO Brian Wuebbels bought 50,000 shares
On Aug. 21, EVP, CAO and CFO Brian Wuebbels bought 50,000 shares at an average price of $11.19. The price of the stock has decreased by 7.95%. SunEdison Inc. has a market cap of $3.25 billion and its shares were traded at around $10.30. The company has a P/S ratio of 1.38.
SunEdison Inc. announced its 2015 second-quarter results with revenues of $455 million and gross profit of $103 million; the net income was $263 million. The 2014 total revenue was $2.48 billion, a 24% increase from the 2013 total revenue. The 2014 gross profit was $221.9 million, a 53% increase from the 2013 gross profit. The 2014 net income was $1.18 billion.
On Aug. 25, Director Emmanuel T. Hernandez bought 10,000 shares at an average price of $9.95. The price of the stock has increased by 3.52%. On Aug. 25, Director Randy H. Zwirn bought 2,500 shares at an average price of $8.95. The price of the stock has increased by 15.08%. On Aug. 21, Director Clayton C. Daley Jr. bought 6,100 shares at an average price of $10.68. The price of the stock has decreased by 3.56%.
Genpact Ltd.: CFO Edward J. Fitzpatrick bought 23,500 shares
On Aug. 20, CFO Edward J. Fitzpatrick bought 23,500 shares at an average price of $22.53. The price of the stock has increased by 3.99%. Genpact Ltd. has a market cap of $5.05 billion, and its shares were traded at around $23.43. The company has a P/E ratio of 26.10 and P/S ratio of 2.17. Over the past five years, Genpact Ltd. had an annual average earnings growth of 9.60%.
Genpact Ltd announced its 2015 second-quarter results with revenues of $609.53 million and gross profit of $243.23 million; the net income was $62.7 million. The 2014 total revenue was $2.28 billion, a 7% increase from the 2013 total revenue. The 2014 gross profit was $901.35 million, an 11% increase from the 2013 gross profit. The 2014 net income was $192 million.
On July 22, President and CEO N. V. Tyagarajan sold 55,889 shares at an average price of $22. The price of the stock has increased by 6.5%. On Aug. 13, Senior Officer Wade William Bristol, sold 655 shares at an average price of $14.66. The price of the stock has increased by 59.82%. On Aug. 13, Director or Senior Officer of Insider or Subsidiar Joseph Dennis Dick, sold 1,030 shares at an average price of $14.66. The price of the stock has increased by 59.82%.
GenMark Diagnostics Inc.: CFO Scott Mendel bought 10,000 shares
On Aug. 24, CFO Scott Mendel bought 10,000 shares at an average price of $9.1. The price of the stock has increased by 10.11%. GenMark Diagnostics Inc. has a market cap of $424.698 million and its shares were traded at around $10.02. The company has a P/S ratio of 12.37.
GenMark Diagnostics Inc. announced its 2015 second-quarter results with revenues of $7.65 million and gross profit of $4.36 million; the net income was $12.15 million. The 2014 total revenue was $30.59 million, a 12% increase from the 2013 total revenue. The 2014 gross profit was $17.47 million, a 48% increase from the 2013 gross profit. The 2014 net income was $38.26 million.
On June 16, President and CEO Hany Massarany sold 1,698 shares at an average price of $9.12. The price of the stock has increased by 9.87%. On March 10, Director Michael Kagnoff bought 5,000 shares at an average price of $11.84. The price of the stock has decreased by 15.37%. On Aug. 11, SVP, International Ingo Chakravarty sold 553 shares at an average price of $8.6. The price of the stock has increased by 16.51%.
